elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q40333043-2DE9175A-1A0B-4294-95A0-A2107CCB3E2F
Q40333043-2DE9175A-1A0B-4294-95A0-A2107CCB3E2F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40333043-2DE9175A-1A0B-4294-95A0-A2107CCB3E2F
Phase I trial of weekly and twice-weekly bortezomib with rituximab, cyclophosphamide, and prednisone in relapsed or refractory non-Hodgkin lymphoma.
P2860
Q40333043-2DE9175A-1A0B-4294-95A0-A2107CCB3E2F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40333043-2DE9175A-1A0B-4294-95A0-A2107CCB3E2F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e7d7241b5abf32c0d4f47f4826ed4cc52c9dae00
P2860
Improved survival of follicular lymphoma patients in the United States.